Transoral outlet reduction: Outcomes of endoscopic Roux-en-Y gastric bypass revision in 284 patients at a community practice.
Endoscopic revision
Gastrojejunal anastomosis
Obesity
Purse-string
Roux-en-Y gastric bypass
Transoral outlet reduction
Weight recurrence
Journal
World journal of gastrointestinal endoscopy
ISSN: 1948-5190
Titre abrégé: World J Gastrointest Endosc
Pays: United States
ID NLM: 101532474
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
received:
31
07
2023
revised:
28
08
2023
accepted:
11
09
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
ppublish
Résumé
Transoral outlet reduction (TORe) is a minimally invasive endoscopic revision of Roux-en-Y gastric bypass (RYGB) for weight recurrence; however, little has been published on its clinical implementation in the community setting. To characterize the safety and efficacy of TORe in the community setting for adults with weight recurrence after RYGB. This is a retrospective cohort study of argon plasma coagulation and purse-string suturing for gastric outlet reduction in consecutive adults with weight recurrence after RYGB at a single community center from September 2020 to September 2022. Patients were provided longitudinal nutritional support Two hundred eighty-four adults (91.9% female, age 51.3 years, body mass index 39.3 kg/m When performed by an experienced endoscopist and combined with longitudinal nutritional support, purse-string TORe is safe and effective in the community setting for adults with weight recurrence after RYGB.
Sections du résumé
BACKGROUND
BACKGROUND
Transoral outlet reduction (TORe) is a minimally invasive endoscopic revision of Roux-en-Y gastric bypass (RYGB) for weight recurrence; however, little has been published on its clinical implementation in the community setting.
AIM
OBJECTIVE
To characterize the safety and efficacy of TORe in the community setting for adults with weight recurrence after RYGB.
METHODS
METHODS
This is a retrospective cohort study of argon plasma coagulation and purse-string suturing for gastric outlet reduction in consecutive adults with weight recurrence after RYGB at a single community center from September 2020 to September 2022. Patients were provided longitudinal nutritional support
RESULTS
RESULTS
Two hundred eighty-four adults (91.9% female, age 51.3 years, body mass index 39.3 kg/m
CONCLUSION
CONCLUSIONS
When performed by an experienced endoscopist and combined with longitudinal nutritional support, purse-string TORe is safe and effective in the community setting for adults with weight recurrence after RYGB.
Identifiants
pubmed: 37900116
doi: 10.4253/wjge.v15.i10.602
pmc: PMC10600692
doi:
Types de publication
Journal Article
Langues
eng
Pagination
602-613Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: Dr. Daniel B Maselli is a consultant for Apollo Endosurgery, with no proprietary relationship. Dr. Christopher E McGowan previously served as a consultant for Apollo Endosurgery from 2019-2022, with no proprietary relationship. Dr. Vibhu Chittajallu, Dr. Lauren L Donnangelo, Dr. Brian Coan, Mr. Chase Wooley, Ms. Areebah Waseem, Ms. Michelle Secic, and Mr. Daniel Lee have no conflicts of interest or financial ties to disclose.
Références
Endoscopy. 2018 Apr;50(4):371-377
pubmed: 29253919
Gastrointest Endosc. 2020 Dec;92(6):1164-1175.e6
pubmed: 32692991
Gastrointest Endosc. 2020 May;91(5):1078-1084
pubmed: 31904378
Obes Surg. 2015 Aug;25(8):1474-81
pubmed: 25595383
Gastrointest Endosc. 2010 Mar;71(3):446-54
pubmed: 20189503
Gastrointest Endosc. 2018 Feb;87(2):442-447
pubmed: 28843586
Obes Surg. 2010 Mar;20(3):349-56
pubmed: 19554382
Surg Endosc. 2018 Jan;32(1):252-259
pubmed: 28664438
N Engl J Med. 2004 Dec 23;351(26):2683-93
pubmed: 15616203
Clin Endosc. 2018 Sep;51(5):430-438
pubmed: 30301319
J Gastrointest Surg. 2023 Aug;27(8):1587-1593
pubmed: 37237090
Obes Surg. 2022 Feb;32(2):273-283
pubmed: 34811645
Obes Surg. 2016 Jul;26(7):1627-34
pubmed: 27138603
N Engl J Med. 2017 Sep 21;377(12):1143-1155
pubmed: 28930514
Endosc Int Open. 2023 May 26;11(5):E538-E545
pubmed: 37251791
Obes Surg. 2022 Dec;32(12):3879-3890
pubmed: 36242680
Curr Obes Rep. 2017 Jun;6(2):187-194
pubmed: 28455679
Gastrointest Endosc. 2023 Aug 1;:
pubmed: 37536634
Obes Surg. 2023 Apr;33(4):1032-1039
pubmed: 36702981
Gastrointest Endosc. 2023 Oct;98(4):552-558
pubmed: 37150416
Endosc Int Open. 2020 Oct;8(10):E1332-E1340
pubmed: 33015335
Surg Endosc. 2023 Jul;37(7):5538-5546
pubmed: 36261645
Endosc Int Open. 2016 Feb;4(2):E222-7
pubmed: 26878054
Gastrointest Endosc. 2018 May;87(5):1222-1228
pubmed: 29108984
Gastrointest Endosc. 2015 Sep;82(3):425-38.e5
pubmed: 26232362
Surg Obes Relat Dis. 2016 Nov;12(9):1640-1645
pubmed: 27989521
Obesity (Silver Spring). 2019 Feb;27(2):217-225
pubmed: 30421862
Gastrointest Endosc. 2020 Jul;92(1):91-96
pubmed: 32112780
Gastroenterology. 2013 Jul;145(1):129-137.e3
pubmed: 23567348
Ther Adv Gastrointest Endosc. 2020 Jun 17;13:2631774520931978
pubmed: 32596663
Endosc Int Open. 2019 Dec;7(12):E1691-E1698
pubmed: 31803819
Obes Surg. 2008 Jun;18(6):648-51
pubmed: 18392907
Gastrointest Endosc. 2020 May;91(5):1067-1073
pubmed: 31816315
Gland Surg. 2016 Dec;5(6):617-624
pubmed: 28149808
Surg Obes Relat Dis. 2022 Sep;18(9):1134-1140
pubmed: 35970741
Obes Surg. 2017 May;27(5):1137-1144
pubmed: 27798793
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290